A 44-year-old patient came into my Warner Robins office for what was nominally a hormone consultation. Twenty minutes in, she told me what she had actually come to talk about. She had been on an SSRI for six years — started for postpartum anxiety, continued through the chaos of her thirties, never seriously revisited — and somewhere along the way her libido had disappeared. Not diminished. Gone. Her marriage was strained. Her primary care physician had told her it was probably perimenopause. Her labs were sent and came back unremarkable. No one had asked the obvious question: what was the SSRI doing.
That conversation happens more than people realize. The list of common medications that produce sexual side effects is long, the side effects are routinely under-discussed at the prescribing visit, and patients spend years attributing the problem to age, stress, hormones, or themselves when the cause is sitting in a pill bottle on the counter.
This article is the conversation I have with patients in the sexual wellness consultation when the workup turns up a medication contributor. It is not a prescription to stop your medication. It is a map of which medications are most often involved, what the mechanism is, and what the realistic options are.
The medications that show up most often
The list of drugs with documented sexual side effects is long. The ones that appear most frequently in my practice, in the order I see them:
SSRIs and SNRIs. Sertraline, escitalopram, fluoxetine, paroxetine, venlafaxine, duloxetine. Sexual side effects affect somewhere between 30 and 70 percent of patients on these medications, depending on the agent and the dose. The pattern is delayed orgasm or inability to orgasm, decreased libido, and in men decreased ejaculatory volume. The mechanism is related to elevated central serotonin tone, which inhibits the dopaminergic and noradrenergic pathways that drive arousal and orgasm. Paroxetine and sertraline are typically the worst offenders; bupropion is the antidepressant least likely to cause this and is sometimes used as an add-on or substitute when sexual side effects are limiting.
Beta-blockers. Metoprolol, atenolol, propranolol, carvedilol. The older non-selective beta-blockers are more strongly associated with erectile dysfunction in men than the newer cardioselective agents, but all of them can contribute. The mechanism involves both vascular effects and central nervous system effects. Patients on beta-blockers for performance anxiety or essential tremor may have alternatives that do not carry this profile; patients on beta-blockers for documented heart failure or post-MI cardioprotection are usually staying on them.
Diuretics. Hydrochlorothiazide and other thiazides have been associated with erectile dysfunction in men. The mechanism is incompletely understood but is thought to involve vascular and possibly hormonal effects. Spironolactone has its own profile — it has anti-androgenic activity that can reduce libido and contribute to ED in men.
Proton pump inhibitors. Long-term PPI use has been associated with reduced testosterone levels in some studies, likely through effects on micronutrient absorption (zinc and magnesium in particular) and possibly through gut microbiome effects on hormonal metabolism. Many patients are on PPIs years past the original indication.
Statins. The literature here is mixed. Some patients report reduced libido on statins, and statins do modestly reduce testosterone production through cholesterol-pathway effects. The cardiovascular benefit for the right candidate clearly outweighs this; the question is whether the patient is the right candidate, which is a different conversation.
Hormonal contraceptives. Combined oral contraceptives suppress free testosterone by raising sex hormone binding globulin. The libido effect is real for many women on combined OCPs and frequently does not fully reverse for some time after discontinuation. Younger patients in particular are often unaware of this association.
Opioids. Chronic opioid use suppresses gonadal axis function in both men and women, producing what is sometimes called opioid-induced androgen deficiency. The pattern includes reduced libido, fatigue, depression, and in men erectile dysfunction. Patients on long-term opioids for chronic pain often have a hormonal picture that looks like primary hypogonadism on labs.
Antihistamines. Sedating antihistamines (diphenhydramine, hydroxyzine) have anticholinergic effects that can affect arousal and lubrication. Chronic daily use is more likely to produce this than occasional use.
Finasteride and dutasteride. The 5-alpha-reductase inhibitors used for benign prostatic hyperplasia and male pattern hair loss have well-documented sexual side effects, including reduced libido, ED, and reduced ejaculatory volume. A subset of patients experience persistent symptoms after discontinuation (post-finasteride syndrome). The decision to start one of these agents in a younger man should include a real conversation about this risk.
The mechanism, in plain language
The sexual response cycle — desire, arousal, orgasm, resolution — depends on several systems operating in coordination. Adequate sex hormones (testosterone in both sexes; estrogen in women). Intact vascular function for arousal and erection. Functional autonomic nervous system signaling. A central nervous system in which the dopaminergic and noradrenergic arousal circuits are not being suppressed by competing inputs.
Each of the medication classes above operates on at least one of these levers. SSRIs suppress the central arousal circuit through serotonergic dominance. Beta-blockers and diuretics affect vascular response. Hormonal contraceptives and opioids reduce available androgen. PPIs and statins have more diffuse effects across multiple pathways. Antihistamines blunt the autonomic signaling that supports arousal.
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
The clinical implication is that a patient with sexual symptoms who is on one or more of these medications has a pre-existing pharmacological contributor that has to be accounted for before any other intervention is layered on. Ordering testosterone in a man on chronic opioids without recognizing the opioid contribution is a setup for an ineffective treatment plan. Recommending the O-Shot for a woman on a high-dose SSRI without addressing the central arousal suppression is a setup for an underwhelming result.
What I look for in the workup
When a patient comes in for a sexual wellness consultation, the medication review is one of the first pieces of the history I take, and I take it in detail. Every prescription medication. Every over-the-counter that is taken regularly. Every supplement. Dose, duration, original indication, current indication, and whether the original problem still exists.
The next move is to ask, for each medication on the list, whether it is still the right tool for the job. Some examples from real conversations:
The SSRI started 8 years ago for situational anxiety that has long since resolved — does the patient still need it? Often, with appropriate primary care or psychiatric coordination, a structured taper is reasonable.
The PPI started for reflux that no longer occurs — has it been re-evaluated? Often the answer is no, and a step-down trial is appropriate.
The beta-blocker started for situational palpitations — does the cardiology indication still hold? A consult with the prescribing cardiologist may open up alternatives.
The combined oral contraceptive started in the patient's 20s and continued reflexively into her 40s — is it still the right choice for her current life situation, given that she is symptomatic from it?
I do not unilaterally adjust a medication that another clinician is managing. What I do is identify the contributors, document them, communicate with the prescribing clinician where appropriate, and build a treatment plan that accounts for the medication picture. Sometimes that means coordinating a taper. Sometimes it means working around the medication with hormone optimization for women, men's hormone therapy, or regenerative interventions like the O-Shot or P-Shot. Sometimes it means recognizing that the medication is staying and the realistic best result is partial.
Honest conversations about partial wins
Not every medication-related sexual side effect can be eliminated. A patient on lifelong cardioprotective beta-blocker therapy after a serious cardiac event is staying on the beta-blocker. A patient with severe recurrent depression who has been stable on an SSRI for a decade may not be a candidate for tapering. A patient on chronic opioids for legitimate severe pain is in a complicated picture.
For these patients, the realistic conversation is about layering interventions that address the modifiable factors. Optimizing testosterone where the labs support it. Addressing vascular health through metabolic and cardiovascular care. Using ED treatment — including PDE5 inhibitors, vacuum-assisted devices, and regenerative interventions — to compensate for what cannot be fully reversed pharmacologically. Improving sleep, alcohol intake, and exercise patterns to support whatever baseline the patient can reach. Most patients can get to a meaningfully better place than where they started, even when the medication itself cannot be changed.
The honest part of the conversation is that "meaningfully better" is not always "the way it was at 28." Setting that expectation at the front end produces a more satisfied patient than promising a complete restoration that the underlying picture cannot support.
Why this conversation does not happen at most prescribing visits
The answer is uncomfortable but worth stating. The visits at which these medications are typically prescribed — primary care, psychiatry, cardiology — are short. The prescribing clinician usually does cover the major side effects in a brief mention. Sexual side effects are often listed but not actively explored, partly because there is not time, partly because the conversation is awkward, partly because by the time the side effect emerges weeks to months later, the patient is reluctant to bring it up.
The sexual wellness consultation, by contrast, is scheduled with time and privacy specifically to have this conversation. Patients who have spent years not knowing where to bring this up frequently find that having a clinician actually ask the question, in detail, without judgment, is itself part of the treatment.
The concrete next step
If sexual symptoms have emerged or worsened in a window that overlaps with starting a new medication — even if that medication was started years ago — bring the full medication list to the private consultation. The comprehensive workup at the first visit will include the medication review, hormone labs, and the additional markers indicated by your specific picture. The treatment plan that follows accounts for what the medications are doing rather than working around the question. Both the Columbus consultation and Warner Robins location run the same protocol. Bring the bottles or a current pharmacy printout if it helps you remember exact doses and start dates. The medication history is one of the highest-yield pieces of the visit.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.